We have tried to substitute the aryloxy group in l-aryloxy-2-oxy-3-guanidinopropanes with an arylamino group offering better synthetic possibilities. In the case of Inderal, such a substitution led to disappearance of the B-adrenoblocking properties [2]. In the synthesis of
